Beckman Coulter Diagnostics has announced a 10 million EUR investment that underscores its commitment to innovation and growth in the region. The investment will enhance Beckman Coulter’s world-class diagnostics production with the addition of two new fully automated reagent filling lines and upgrades to the site’s infrastructure, boosting both efficiency and capacity.
The company is actively hiring for 50 open roles and also announced 30 additional jobs arising, to be recruited between 2025 and 2027 for highly-skilled professionals at its County Clare facility for key functions such as Production Operations, Quality & Regulatory Affairs, Research & Development, etc.
Today’s event at Beckman Coulter’s high-tech site at O´Callaghan´s Mills, Co. Clare was attended by Beckman Coulter’s Ireland-born president Kevin O’Reilly, who was appointed earlier this year to lead the company and its 11,000 employees globally. Others in attendance included European Commissioner-designate Michael McGrath, as well as other national and local public representatives and industry stakeholders.
Beckman Coulter’s economic contribution is significant to East Clare and the wider Mid-West region thanks to the 550 plus jobs it provides in its facility. Employment at the site is anticipated to rise to 600 jobs, with headcount figures having almost doubled since 2018.
An economic impact assessment carried out by independent market researchers Repucon revealed that the economic impact of the company was 183 million EUR based on annual GVA (Gross Value Added) in 2023. The report also shows that the Employment Income Impact of the company for the regional economy in 2023 was 55 million EUR, of which 22 million EUR is provided through its 220 plus employees living in Co. Clare. Over the next five years, Beckman Coulter’s regional employment income impact is projected to generate 380 million EUR.
Read more: Beckman Coulter and MeMed partner on host immune response test
Beckman Coulter says it is an example of how cutting-edge foreign direct investment in Ireland can coexist in harmony with its precious environment. Beyond its people, the company also recognises its responsibilities to local farmland, with its 15,900m2 facility located within a 120Ha farmland.
A focus on sustainability at the site has led to the company making use of renewable energy, as well as a wormery waste treatment plant, water treatment plant, development of a 5km nature trail, and supporting the farmland ecosystem with over 240,000 bees living on-site.
“I’m incredibly happy about Beckman Coulter’s significant contributions to my home country, Ireland, not only to the local economy but also to enhancing healthcare every day,” said Kevin O’Reilly, president of Beckman Coulter Diagnostics.
EU Commissioner-designate Michael McGrath said, “Beckman Coulter is a superb case study of the impact of foreign direct investment in Ireland, including into rural communities. There are few settings more rural for an FDI than this site in East Clare. Yet the Beckman Coulter produces cutting-edge diagnostic tools here that are critical to the delivery of healthcare across the globe and at the same time makes a massive economic impact on this area. This reflects brilliantly on Beckman Coulter, on the skills pool available in Ireland and on how big industry and the environment can cohabit perfectly here.”
Mary Buckley, Executive Director, IDA Ireland said: “Beckman Coulter has had a presence in Co. Clare since 2005. Today’s announcement of a 10m EUR expansion is very welcome news and exemplifies IDA Ireland’s continued commitment to winning jobs and investment for every region in Ireland. I wish Beckman Coulter continued success.”
One of the top 3 diagnostics companies worldwide, Beckman Coulter Diagnostics employs over 11,000 people all over the world and plays a major role in world health. Every hour around the world, more than 1 million samples – representing up to 1 million people – are analysed in hospitals using Beckman Coulter instruments. In Ireland, hospitals in Cork, Kerry, and Mayo are prime examples of facilities using Beckman Coulter’s instruments.